Paulson & Co. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2017$9,742,000
+19.0%
210,500
-9.2%
0.13%
+21.1%
Q1 2017$8,185,000
+541.0%
231,800
+127.3%
0.11%
+581.2%
Q4 2016$1,277,000
-9.6%
102,0000.0%0.02%
+6.7%
Q3 2016$1,413,000
+40.2%
102,0000.0%0.02%
+50.0%
Q2 2016$1,008,000
-41.6%
102,0000.0%0.01%
-23.1%
Q1 2016$1,725,000
+244.3%
102,000
+353.3%
0.01%
+333.3%
Q4 2015$501,00022,5000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 3,791,300$3,715,4744.82%
Two Seas Capital LP 7,672,170$7,518,7271.51%
Parkman Healthcare Partners LLC 1,997,071$1,957,1300.36%
Monaco Asset Management SAM 1,171,779$1,148,3430.34%
TANG CAPITAL MANAGEMENT LLC 1,850,000$1,813,0000.26%
Ikarian Capital, LLC 1,737,636$1,702,8830.20%
PLATINUM INVESTMENT MANAGEMENT LTD 3,189,517$3,125,7270.12%
GSA CAPITAL PARTNERS LLP 1,116,655$1,0940.09%
XTX Topco Ltd 519,129$508,7460.09%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 60,000$58,8000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders